HQL
Tekla Life Sciences Investors
18.20$
-2.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.2% | -10.7% | +12.1% | +2.2% | -19.1% | +25.1% | +10.3% | -22.4% | -2.9% | +14.4% | +11.9% | |
| – | +356.7% | -7.4% | -96.9% | +1,666.9% | -54.5% | -98.5% | +95.8% | +331.3% | +708.6% | -94.4% | +344.8% | |
| – | -82.8% | +2,398.5% | +6,010.9% | -100.0% | +2,739,261.0% | -542.2% | – | -55.1% | +7.2% | -99.8% | +7,553,700.0% | |
| – | -82.8% | +2,447,311.7% | -93.8% | -100.0% | +2,807,745.0% | +342.2% | -100.0% | -55.1% | +3,425,175.7% | -100.0% | +7,553,700.0% | |
| – | +155.8% | +572.1% | -99.8% | +61,636.0% | -61.0% | -98.3% | +103.4% | +314.7% | +709.1% | -95.4% | +392.5% | |
| – | – | – | – | -100.0% | – | – | – | +93.9% | -39.6% | – | – | |
| – | +564.5% | -46.9% | -25.5% | +50.3% | -5.1% | -78.9% | +1,705.3% | +56.6% | -96.0% | +33.2% | +94.2% | |
| – | +564.5% | -46.9% | -50.7% | +79.3% | +20.3% | -79.4% | +1,748.6% | -52.5% | – | – | -18.9% | |
| – | – | – | – | – | – | – | +71,921.7% | +10.5% | – | – | – | |
| – | +2,892.7% | -50.0% | -37.7% | +79.3% | +20.3% | – | – | +3,292.1% | – | – | +40,151.3% | |
| – | +4.2% | -10.3% | +12.4% | +2.0% | -19.3% | +26.0% | +8.2% | -24.0% | +1.0% | +14.4% | +11.7% | |
| – | +0.1% | -101.5% | – | – | -72.9% | +231.2% | +18.6% | -93.7% | -115.5% | – | +75.9% | |
| – | +3.6% | +5.4% | +3.0% | +4.9% | +3.5% | +2.9% | +1.7% | +5.9% | +10.2% | -0.8% | +2.9% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.